1. Home
  2. TKNO vs SOR Comparison

TKNO vs SOR Comparison

Compare TKNO & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • SOR
  • Stock Information
  • Founded
  • TKNO 1996
  • SOR 1968
  • Country
  • TKNO United States
  • SOR United States
  • Employees
  • TKNO N/A
  • SOR N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • SOR Investment Managers
  • Sector
  • TKNO Health Care
  • SOR Finance
  • Exchange
  • TKNO Nasdaq
  • SOR Nasdaq
  • Market Cap
  • TKNO 430.2M
  • SOR 348.7M
  • IPO Year
  • TKNO 2021
  • SOR N/A
  • Fundamental
  • Price
  • TKNO $5.19
  • SOR $41.51
  • Analyst Decision
  • TKNO Buy
  • SOR
  • Analyst Count
  • TKNO 1
  • SOR 0
  • Target Price
  • TKNO $5.00
  • SOR N/A
  • AVG Volume (30 Days)
  • TKNO 536.1K
  • SOR 16.2K
  • Earning Date
  • TKNO 03-04-2025
  • SOR 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • SOR 7.24%
  • EPS Growth
  • TKNO N/A
  • SOR N/A
  • EPS
  • TKNO N/A
  • SOR 6.50
  • Revenue
  • TKNO $37,745,000.00
  • SOR N/A
  • Revenue This Year
  • TKNO $12.70
  • SOR N/A
  • Revenue Next Year
  • TKNO $19.79
  • SOR N/A
  • P/E Ratio
  • TKNO N/A
  • SOR $6.41
  • Revenue Growth
  • TKNO 2.89
  • SOR N/A
  • 52 Week Low
  • TKNO $1.16
  • SOR $36.41
  • 52 Week High
  • TKNO $10.37
  • SOR $42.75
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 36.06
  • SOR 42.46
  • Support Level
  • TKNO $5.22
  • SOR $41.27
  • Resistance Level
  • TKNO $5.69
  • SOR $42.50
  • Average True Range (ATR)
  • TKNO 0.47
  • SOR 0.84
  • MACD
  • TKNO 0.05
  • SOR 0.02
  • Stochastic Oscillator
  • TKNO 23.21
  • SOR 22.09

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

Share on Social Networks: